Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Application of 18F-Fapi PET/MRI in the Assessment of Myelofibrosis: A Multi-Center Prospective Observational Study

Dan Tian, Jun Zhang, Yuanyuan Zhu, Weijia Huang, Jin Zhang, He Huang, Xinhui Su, Jie Sun

Blood (2024) 144 (Supplement 1): 3599.

https://doi.org/10.1182/blood-2024-207873

Published: 2024

Journal Articles

Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients

Weiyan Zheng, Shan Fu, Xuepin Luo, Yuanyuan Zhu, He Huang

Blood (2023) 142 (Supplement 1): 5934.

https://doi.org/10.1182/blood-2023-191155

Published: 2023

Journal Articles

Prognostic Risk Factors for Patients with Candida Tropicalis Fungemia Infections and Hematological Malignancies

Haisu Zhao, Shan Fu, Yuanyuan Zhu, He Huang, Weiyan Zheng

Blood (2023) 142 (Supplement 1): 5846.

https://doi.org/10.1182/blood-2023-189437

Published: 2023

Journal Articles

Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study

Yuanyuan Zhu, Weijia Huang, Jinya Lin, Zhen Cai, Xiujin Ye, Shanshan Pei, Ying Xie, Xiaoqing Zou, Shaoqi Zhang, He Huang, Jie Sun

Blood (2023) 142 (Supplement 1): 1524.

https://doi.org/10.1182/blood-2023-186579

Published: 2023

Journal Articles

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

Shuyue Bao, Jinya Lin, Yuanyuan Zhu, Weijia Huang, Weiyan Zheng, Guoqing Wei, Zhen Cai, Yi Luo, Yi Zhao, Jimin Shi, He Huang, Jie Sun

Blood (2023) 142 (Supplement 1): 5867.

https://doi.org/10.1182/blood-2023-186943

Published: 2023

Journal Articles

De Novo Point Mutation of RPL31 in Diamond-Blackfan Anaemia: A Story from Patient to Zebrafish

Yuanyuan Zhu, MD, Honghu Li, doctoral student, Weiyan Zheng, MD, Shuyang Cai, doctoral student, Yibo Wu, doctoral student, He Huang

Blood (2019) 134 (Supplement_1): 5018.

https://doi.org/10.1182/blood-2019-129708

Published: 2019

Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang

Blood (2019) 134 (Supplement_1): 2668.

https://doi.org/10.1182/blood-2019-127594

Published: 2019

Journal Articles

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

Yi Luo, Yamin Tan, Yongxian Hu, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Yuanyuan Zhu, Jian Yu, Jiasheng Wang, He Huang, MD PhD

Blood (2016) 128 (22): 3439.

https://doi.org/10.1182/blood.V128.22.3439.3439

Published: 2016

Journal Articles

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Yuanyuan Zhu, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, He Huang

Blood (2014) 124 (17): 2735–2743.

https://doi.org/10.1182/blood-2014-04-571570

Published: 2014

Journal Articles

Comparison Of Allogeneic Hematopoietic Cell Transplantation Versus Chemotherapy In Patients With Acute Myeloid Leukemia In First Remission

Xiaoyu Lai, Mingyu Zhu, Yi Luo, Yamin Tan, Weiyan Zheng, M.D., Yuanyuan Zhu, Jimin Shi, He Huang, MD, PhD.

Blood (2013) 122 (21): 5546.

https://doi.org/10.1182/blood.V122.21.5546.5546

Published: 2013

Journal Articles

Prospective Evaluation Of Allo-HSCT From Haploidentical-Related Donors Compared With Matched Sibling Donors and Unrelated Donors For Patients With Hematological Malignancies: Results From An Open-Label Trial

Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, MD, PhD, Wanzhuo Xie, M.D. Ph.D., Weiyan Zheng, M.D., Yuanyuan Zhu, Xiujin Ye, M.D. Ph.D., Zhen Cai, MD, Maofang Lin, He Huang

Blood (2013) 122 (21): 3338.

https://doi.org/10.1182/blood.V122.21.3338.3338

Published: 2013

Journal Articles

Minimal Residual Disease Levels At Time Of CR1 and Transplant Predict Outcome In Philadelphia Chromosome-Negative Adult ALL

Mingming Zhang, PhD, Yi Luo, Xiaoyu Lai, Yamin Tan, Weiyan Zheng, M.D., Yuanyuan Zhu, Jimin Shi, He Huang, MD, PhD.

Blood (2013) 122 (21): 713.

https://doi.org/10.1182/blood.V122.21.713.713

Published: 2013

Journal Articles

Anti-Proliferative Effect of Rapamycin on Human T Cell Leukemia Cell Line Jurkat by Cell Cycle Arrest and Telomerase Inhibition.

Yanmin Zhao, M.D., Yun Xu, M.D., Jianping Lan, M.D., Ph.D., Yuanyuan Zhu, M.D., Ph.D., He Huang, MD, PhD

Blood (2007) 110 (11): 4285.

https://doi.org/10.1182/blood.V110.11.4285.4285

Published: 2007

Journal Articles

Sumoylation of TRF1 Is Essential for Its Recruitment to ALT-Associated PML Bodies.

Jian Yu, M.D., Jianping Lan, M.D., Ph.D., Yuanyuan Zhu, M.D., Ph.D., Xiaoyu Lai, M.D., He Huang, MD, PhD

Blood (2007) 110 (11): 4169.

https://doi.org/10.1182/blood.V110.11.4169.4169

Published: 2007

Journal Articles

Chromosomal Instability Induced by Overexpression of Telomere Repeats Binding Factor 1.

Jianping Lan, MD, He Huang, PhD, MD, Yuanyuan Zhu, PhD, Jian Yu, PhD, Jie Sun, PhD

Blood (2005) 106 (11): 4398.

https://doi.org/10.1182/blood.V106.11.4398.4398

Published: 2005

Journal Articles

Study on Expression of Telomerase Inhibitor Pinx1 in Leukemia Cells and Its Correlation with Telomerase Activity.

Jie Sun, PhD, He Huang, PhD, MD, Yuanyuan Zhu, PhD, Jianping Lan, PhD, Xiaoyu Lai, MD

Blood (2005) 106 (11): 4375.

https://doi.org/10.1182/blood.V106.11.4375.4375

Published: 2005

Journal Articles

The Fluctuation of Telomere Repeat Binding Factor 1 during Cell Cycle and Its Localization in Telomerase-Positive and Negative Cells.

Jianping Lan, M.D., He Huang, Ph.D, M.D, Yuanyuan Zhu, Jie Sun, Ph.D.

Blood (2004) 104 (11): 4326.

https://doi.org/10.1182/blood.V104.11.4326.4326

Published: 2004

NARROW

Application of 18F-Fapi PET/MRI in the Assessment of Myelofibrosis: A Multi-Center Prospective Observational Study

Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients

Prognostic Risk Factors for Patients with Candida Tropicalis Fungemia Infections and Hematological Malignancies

Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

De Novo Point Mutation of RPL31 in Diamond-Blackfan Anaemia: A Story from Patient to Zebrafish

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Comparison Of Allogeneic Hematopoietic Cell Transplantation Versus Chemotherapy In Patients With Acute Myeloid Leukemia In First Remission

Prospective Evaluation Of Allo-HSCT From Haploidentical-Related Donors Compared With Matched Sibling Donors and Unrelated Donors For Patients With Hematological Malignancies: Results From An Open-Label Trial

Minimal Residual Disease Levels At Time Of CR1 and Transplant Predict Outcome In Philadelphia Chromosome-Negative Adult ALL

Anti-Proliferative Effect of Rapamycin on Human T Cell Leukemia Cell Line Jurkat by Cell Cycle Arrest and Telomerase Inhibition.

Sumoylation of TRF1 Is Essential for Its Recruitment to ALT-Associated PML Bodies.

Chromosomal Instability Induced by Overexpression of Telomere Repeats Binding Factor 1.

Study on Expression of Telomerase Inhibitor Pinx1 in Leukemia Cells and Its Correlation with Telomerase Activity.

The Fluctuation of Telomere Repeat Binding Factor 1 during Cell Cycle and Its Localization in Telomerase-Positive and Negative Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only